Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.11 0.005
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.11 0.007
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.007
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.11 0.007
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.008
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.1 0.009
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.081 0.009
mRNA parbendazole CTRPv2 pan-cancer AAC 0.082 0.01
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.092 0.01
Download CSV